investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
Catherine Ju-Ying Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Catherine Ju-Ying Wu
Dana-Farber Cancer Institute
Boston, United States
Related projects
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
Honami Naora
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
Leukaemia
Daniel Fowler
Combination Gene Therapy and Th1/Th2 Therapy
Leukaemia
Hematology and hematologic malignancies
Katerina V Gurova
Modulation of cancer specific transcriptional factors with small molecules
Leukaemia
Michael Gottesman
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Leukaemia
Peter Aplan
Collaborative Pathways that Lead to Leukemia – Rockville
Leukaemia
Pathology
Hematology and hematologic malignancies
Ulrich G. Steidl
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
Leukaemia
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
Genoveffa Franchini
T-Cell Transformation by Oncoviruses
Leukaemia
Pathology
Hematology and hematologic malignancies